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Background: Filaggrin (FLG) gene mutations, which result in
complete or incomplete loss of proFLG/FLG peptides, have been
reported as an important predisposing factor for atopic dermatitis
(AD) and secondary atopic phenotypes such as atopic asthma.
Method: The presence of the protein FLG in the skin was
evaluated at birth on 12 infants using Raman spectroscopy;
these 12 infants were monitored for 1 year to see whether
they developed AD. Three different statistical analysis pro-
cedures, two of which involved principal component analysis
(PCA), were performed on the Raman spectra in order to
determine the FLG content.
Results: The infants who had a lower FLG content, deter-
mined using any of the three statistical analysis procedures
proposed, were also the ones that clinically developed AD.
Conclusion: The results suggest that Raman spectroscopy
and statistical analysis such as PCA could be used as an
early detection procedure for FLG -related AD and as a
possible quantitative marker for FLG gene mutations.
Key words: atopic dermatitis – filaggrin – Raman spectro-
scopy – principal component analysis
Abbreviations: FLG: filaggrin; AD: atopic dermatitis; PCA:
principal component analysis; SC: stratum corneum; NMF:
natural moisturizing factor.
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FILAGGRIN (FLG) IS a key protein required forthe formation of the stratum corneum (SC)
barrier (1); it plays an important role in the
maintenance of the skin barrier function (2) and
is essential for SC hydration (1).
FLG gene mutations have been reported as an
important predisposing factor for atopic derma-
titis (AD) and secondary atopic phenotypes such
as atopic asthma (3), which suggests that a skin
barrier defect is a primary key event leading to
allergic sensitization and development of AD and
related allergic phenotypes (3).
Kezic et al. (1) used confocal Raman micro-
spectroscopy to measure natural moisturizing
factor (NMF) as a function of SC depth, showing
that individuals who are carriers of FLG-null
mutations have lower levels of the NMF in the
SC and a higher transepidermal water loss as
compared with non-carriers; these findings sug-
gest that the measurement of these parameters
could be used as a marker of FLG gene status (1).
Nemoto-Hasebe et al. (2), using immunohisto-
chemistry, showed that FLG gene mutations result
in complete or incomplete loss of proFLG/FLG
peptides.
Principal component analysis (PCA) is a multi-
variate technique that can be applied to a data set
without any prior knowledge about its nature,
making it an unsupervised data analysis techni-
que (4, 5). However, the correct analysis of the
results of the PCA requires an understanding of
the type of data being evaluated and how the
given results are relevant to the problem.
In this work, the presence of the protein FLG
in the skin is detected using Raman spectroscopy
and PCA as an early detection procedure for FLG-
related AD and as a possible marker for FLG gene
mutations. The technique proposed produces
quantitative parameters that positively identify
those patients who developed AD by using a
non-invasive optical procedure at birth, when no
sign or symptom of the disease was evident.
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Materials and Methods
Twelve healthy infants born without complica-
tions from healthy mothers participated in this
study. Informed consent was obtained from the
mothers of all the participants and the study was
approved by the ethics committee of the Hospital
‘Dr Ignacio Morones Prieto’.
Raman scattering measurements were per-
formed on the right thigh for each infant at birth;
the measurements were performed at room
temperature using a Raman Systems R3000 spec-
trometer (Ocean Optics, Dunedin, FL, USA) with a
785 nm laser diode, a spectral resolution of 8 cm 1
and a laser power of 90 mW. The irradiance of this
laser diode is below the ANSI standard for skin
and none of the participants showed any kind
of discomfort when the measurement was per-
formed. The measurements were performed in
the 200–1800 cm 1 spectral range and the instru-
ment was calibrated using a Teflon standard every
day before each round of measurements.
The Raman measurements included one in vitro
Raman spectrum of pure FLG human recombinant
protein (GenWay Biotech Inc., San Diego, CA,
USA) in order to have a fixed spectrum that would
help us assess the amount of FLG in the measured
spectra. For this measurement, a quartz cuvette
and a 300 mW laser power were used.
The participants of this study were monitored
for 1 year to see whether any of them developed
AD. The dermatologist’s diagnosis of AD was
made according to standard criteria in the pre-
sence of a chronic or chronically relapsing pruri-
tic dermatitis with the typical morphology and
distribution (6, 7).
Three different types of statistical analyses
were performed on the measured spectra to
obtain quantitative parameters related to the
problem. The first analysis consisted in calculat-
ing the cross-correlation between the spectra in
order to determine the similarities between spec-
tra and relate them to clinical findings. Also,
the PCA method was applied to the set of data.
The second analysis consisted in analyzing the
FLG content of each measured spectrum by
reconstructing the measured spectra using only
the principal components relevant to the FLG and
the third statistical approach consisted in con-
structing a two-dimensional plot of the first and
second principal components and comparing the
location of the spectrum of FLG with the location
of the measured spectra.
Using the cross-correlation matrix, the relation
between a given set of spectra can be obtained (8);
the element (i, j) of this matrix quantifies the
similarity of spectrum i to spectrum j. In this
work, it is of interest to determine how the FLG
spectrum is related to the patients’ spectra; as a
first approach, the cross-correlation matrix was
used to find these similarities. However, there are
other statistical techniques, such as the PCA, that
provide a more in-depth analysis of the structure
of the variance–covariance matrix between spec-
tra. It is worth noting that the cross-correlation
matrix is a normalized version of the variance–
covariance matrix of the data (8, 9).
The N measured spectra were sampled at M
different wavenumbers and arranged as an
M  N matrix that can be seen as M, N-dimen-
sional vectors. Applying the PCA technique to
these data, the PCA yields three types of results:
N principal components, an N  N matrix con-
taining the coefficients for the transformation
between the original data and the principal com-
ponents, and N eigenvalues describing the im-
portance of the corresponding principal
components. The original N experimental spectra
are transformed into a new set of N ‘synthetic’
spectra called principal components. These prin-
cipal components are independent of each other;
statistically, we could say that they are uncorre-
lated, as opposed to the original ones, which
show a non-negligible cross-correlation between
them. Besides, PCA yields an N  N matrix with
the coefficients to transform the original spectra
into the new uncorrelated ones, and vice versa.
Also, these principal components are given in
decreasing order of importance, which means
that the first principal component can explain
the largest quantity of the variance of the original
data, the second one explains more variance than
the third, and so on. In the terminology used by
the PCA, we call these variance contributions as
eigenvalues. Mathematically, they are the diago-
nal of the covariance matrix among principal
components. One of the advantages of the PCA
is that, by evaluating the relative importance of
the consecutive principal components, it is pos-
sible to reduce the dimension of the data set by
finding a smaller collection of spectra that explain
a given and acceptable amount of variance. On
the other hand, when advancing towards the last
principal component, the consecutive PC can be
grouped together and form processes that are
typically explained as noise contributions (10, 11).
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This grouping is based on a robust statistical
criterion that involves the number of spectral points
measured and the desired level of confidence for
the grouping of the principal components.
Taking into account the properties of PCA, a
method was developed to analyze Raman spec-
tra; the method consisted of including the FLG
spectrum with the original data set containing
the Raman spectra of the patients, and analyzing
the results obtained by applying the PCA
method. The eigenvalues were grouped together
to reduce the dimension of the data and only the
first independent principal components were
taken and the rest were considered to be noise
contributions. Afterwards, the principal compo-
nents that are FLG related are identified. A new
set of reconstructed spectra is generated using
only the FLG-related principal components and
compared with the original ones. The square
mean deviation between the original and the
reconstructed spectra is calculated for each spec-
trum in order to determine the contribution of the
FLG-related principal components to the original
spectra. A larger square mean deviation will
mean that those spectra will have a lower FLG
contribution, which might indicate a degraded or
the absence of FLG. At the same time, we identify
those principal components that make a lower
contribution to the FLG spectrum. The coefficients
of the patients’ spectra for these FLG-non-related
components were used to locate these spectra with
respect to the FLG. Then we can identify those
spectra located farther apart from the FLG position.
All the mathematical analysis was performed
using the computational package Matlab (The
Mathworks Inc., Natick, MA, USA) and its Sta-
tistics toolbox.
Results
From the 12 infants measured and monitored, three
of them developed AD in the course of 1 year.
A statistical analysis was performed on the
12 Raman spectra obtained from the infants at
birth and the Raman spectrum of the protein
FLG. These 13 spectra were measured over a
spectral range from 300.17 to 1783.99 cm 1,
with 1484 data points. Therefore, the data matrix
used in this analysis has a dimension of
1484  13. The measured spectra were processed
in order to remove fluorescence.
Figure 1 shows three spectra corresponding to
FLG (black solid line), a patient who developed
AD (gray dashed line), and another one who
remained healthy (gray solid line).
Figure 2(a) shows the absolute value of the
cross-correlation matrix between spectra. The
absolute value was used because some of the
elements were negative. The FLG data location is
labeled as FLG. Figure 2(b) shows the correlation
of the patient’s spectra with the FLG spectrum;
the lower values of the cross-correlation corre-
spond to the patients who later developed the
disease (patients #1, #9, and #11 are plotted as
gray circles). It is worth noting that other patients
(such as #4 and #7) also have low cross-correla-
tion values. From these plots, it can be seen that
the cross-correlation can identify those spectra
that have a lower FLG component, which would
indicate a larger probability of developing AD.
In order to obtain a more in-depth analysis of
the influence of the FLG spectrum over the
measured spectra, a PCA was applied to the
dataset, producing 13 eigenvalues, which are
plotted in Fig. 3. Using a statistical criterion to
group together the principal components (10), we
find that, with a level of confidence of 99%, the
first eight components are statistically indepen-
dent from each other, and after the eighth com-
ponent, there is a statistical dependence between
them that may be associated with noise (10). The
first eight principal components explain 99.84%
of the total variance of the data; this limit has
been represented in Fig. 3 as a solid vertical line.
The criterion to select these principal compo-
nents is based on the inner connections that could
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Fig. 1. Plot of three spectra used in this analysis. The solid black
spectrum corresponds to the filaggrin, the dashed gray one is for a
patient who developed atopic dermatitis (patient #1), and the solid
gray spectrum corresponds to a healthy patient (patient #4). These
spectra have been pre-processed to eliminate fluorescence.
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be established because of statistical uncertainties
related to the normality of the data. Then, some
principal components cannot be taken individu-
ally because of these inner relations. Together,
these linked principal components describe a so-
called process. Typically, these processes are as-
sociated with noise. In our analysis, we have
preferred to limit our study to those principal
components that can certainly be considered as
independent.
Because we are mainly interested in the FLG
contribution, special attention is focused on the
expansion of the FLG spectrum in terms of the
principal components. Figure 4 represents the coef-
ficients of this expansion. It can be seen that the first
two principal components make an almost negli-
gible contribution to the FLG spectrum, and that
the main contributions emerge from principal
components #3, #4, #5, and #6. Therefore, in order
to reduce the dimension of the original data while
maintaining the FLG-related information, we will
only consider up to principal component #6.
The criterion has been to neglect those contribu-
tions smaller than those from principal components
above #8. This limit has been represented as a
dashed line both in Figs 3 and 4.
The contribution of the FLG spectrum in the
original spectra can be calculated by first recon-
structing the original data using only those
principal components relevant to the FLG. This
means that the reconstruction is carried out by
selecting principal components #3, #4, #5, and #6.
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Fig. 3. Semilog plot of the relative weight of the eigenvalues of the
principal components. After the eighth principal component (PC), the
successive principal components can be combined into processes that
can be interpreted as noise. The dashed line represents a limit when
considering the filaggrin contribution.
Fig. 4. Coefficient of the filaggrin spectrum in terms of the principal
components. The solid line represents the limit in the number of
significant principal components when a statistical discrimination
criterion is applied. The dashed line is placed to indicate that we
neglect the contribution of the principal components #7 and #8.
Fig. 2. (a) Cross-correlation matrix of the spectra as a gray-level map
and (b) shows the cross-correlation of the filaggrin (FLG) spectrum
with the spectra of the patients. FLG labels the FLG data location
[the patients developing atopic dermatitis (AD) are plotted with
gray circles].
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It is worth noting that these four principal compo-
nents explain only 5.83% of the total variance of the
data; however, their contribution is quite relevant
in order to analyze the amount of FLG in the
patients’ spectra. The reconstructed spectra are
compared with the original ones and the standard
deviation of the difference is evaluated. Figure 5
shows this evaluation for the 13 spectra. We may
see that the FLG spectrum shows the minimum
standard deviation, as it should be because we are
using the most significant principal components to
the FLG. At the same time, those spectra showing a
larger standard deviation are the ones who have a
lower FLG component and who were also the ones
who eventually developed AD (patients #1, #9, and
#11). This identification is made with better speci-
ficity than when using only the cross-correlation
between spectra.
As a complementary check of the usefulness of
the PCA method, the behavior of the first two
principal components was evaluated; these two
components represent 93.86% of the total var-
iance of the original data. As mentioned before,
the coefficients of the FLG spectrum for these
two principal components are almost negligible
(see Fig. 4). Therefore, we can say that these two
principal components are not FLG-related and
they represent the lack of FLG in the Raman
spectra. The original data can be represented as
a bi-dimensional plot having as coordinates the
absolute value of the coefficients of the spectra for
the first and the second principal components
(Fig. 6). The gray dots correspond to those infants
who developed AD; the rest of the patients are
grouped together around the location of the FLG
spectrum (represented as a black dot). This result
also indicates that this approach identifies
patients who developed the disease.
Discussion
Loss-of-function mutations in the FLG gene con-
tribute to the most prevalent skin disorders of
cornification, ichthyosis vulgaris, and also show a
strong association with AD; however, the detec-
tion of these mutations by genotyping consists of
an invasive procedure that requires expensive
equipment that is generally not easily available.
Raman spectroscopy is a non-invasive proce-
dure that can provide information on the molecu-
lar structure of the skin. The analysis of the
cross-correlation matrix between spectra and the
PCA were used in order to extract relevant and
quantitative information from the Raman spectra.
Before applying the PCA method, the cross-
correlation matrix was calculated; this matrix
showed that those spectra showing a cross-corre-
lation closer to zero with the FLG spectrum were
the ones corresponding to the infants who devel-
oped AD; however, spectra of subjects who
remained healthy also resulted in low cross-
correlation values. The advantage of using the
cross-correlation method is that it does not need
a database of Raman spectra. The correlation
between spectra can be evaluated using only
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Fig. 5. Quadratic difference between the original spectra and the ones
reconstructed using only those principal components with relevance in
the filaggrin spectrum. The gray circles represent those patients
developing atopic dermatitis (AD).
Fig. 6. Location of the spectra in the principal component (PC) space
using only the first and second PCs. The gray dots represent those patients
developing the disease. The black dot represents the filaggrin spectrum.
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the measured spectrum and the Raman spectrum
of FLG.
A new approach to improve the specificity that
involves PCA was proposed to identify those
principal components related to the FLG spec-
trum. These selected principal components were
used to reconstruct the measured spectra and
later compared with the original ones. The dif-
ference between the reconstructed and the origi-
nal data represents the lack of FLG in the spectra.
Comparison of these results with the clinical
evaluation 1 year after the measurements showed
that those subjects with less FLG developed AD.
The advantage of using this method is that it does
not depend strongly on the set of data and it was
useful in identifying the subjects who later devel-
oped the disease.
A third method used to analyze the content of
FLG in the Raman spectra was performed by
constructing a two-dimensional graph of the first
two principal components of the dataset where
the FLG made a lower contribution. Using
this graph, the subjects who later developed the
disease were the ones who were located farther
apart from the FLG spectrum.
From the findings reported above, it can be
concluded that it is possible to determine which
infants are more susceptible to develop AD by
taking a Raman spectra of their skin at birth,
when no sign or symptom of the disease
had developed, and analyzing the content of the
protein FLG by any of the three different statis-
tical analysis techniques presented. This quanti-
tative approach could be used as an early
detection procedure for FLG-related AD and as
a possible marker for FLG gene mutations.
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